Cargando…
Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists?
SIMPLE SUMMARY: The quantification of PD-L1 expression in tumor samples through the tumor proportion score (TPS) and the combined positive score (CPS) conditions provides access to anti-PD-1/PD-L1 immunotherapy in patients with various solids cancers. Reproducibility studies have shown very heteroge...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216272/ https://www.ncbi.nlm.nih.gov/pubmed/37345105 http://dx.doi.org/10.3390/cancers15102768 |
_version_ | 1785048258509275136 |
---|---|
author | Mercier, Anaïs Conan-Charlet, Virginie Quintin-Roué, Isabelle Doucet, Laurent Marcorelles, Pascale Uguen, Arnaud |
author_facet | Mercier, Anaïs Conan-Charlet, Virginie Quintin-Roué, Isabelle Doucet, Laurent Marcorelles, Pascale Uguen, Arnaud |
author_sort | Mercier, Anaïs |
collection | PubMed |
description | SIMPLE SUMMARY: The quantification of PD-L1 expression in tumor samples through the tumor proportion score (TPS) and the combined positive score (CPS) conditions provides access to anti-PD-1/PD-L1 immunotherapy in patients with various solids cancers. Reproducibility studies have shown very heterogeneous inter- and intra-pathologist agreements, from poor to excellent ones, in TPS and CPS quantification. We studied the inter- and intra-pathologist agreements in TPS and CPS quantification comparing single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor nuclear markers, trying to improve the distinction between tumor cells and immune cells necessary to TPS and CPS calculations. Our study concluded in excellent (TPS) to good (CPS) inter- and intra-pathologist agreements with both S-IHC and D-IHC with slightly higher intraclass correlation coefficients using D-IHC. D-IHC could help the pathologists to quantify PD-L1 expression through TPS and CPS for subsequent therapeutic choices in patients with advanced cancers. ABSTRACT: We studied the pathologists’ agreements in quantifying PD-L1 expression through the tumor proportion score (TPS) and the combined positive score (CPS) using single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor cell markers. S-IHC and D-IHC were applied to 15 cancer samples to generate 60 digital IHC slides (30 whole slides images and 30 regions of interest of 1 mm(2)) for PD-L1 expression quantification using both TPS and CPS, twice by four pathologists. Agreements were estimated calculating intraclass correlation coefficients (ICC). Both S-IHC and D-IHC slides analyses resulted in excellent (for TPS, ICC > 0.9) to good (for CPS, ICC > 0.75) inter- and intra-pathologist agreements with slightly higher ICC with D-IHC than with S-IHC. S-IHC resulted in higher TPS and CPS than D-IHC (+5.6 and +6.1 mean differences, respectively). High reproducibility in the quantification of PD-L1 expression is attainable using S-IHC and D-IHC. |
format | Online Article Text |
id | pubmed-10216272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102162722023-05-27 Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? Mercier, Anaïs Conan-Charlet, Virginie Quintin-Roué, Isabelle Doucet, Laurent Marcorelles, Pascale Uguen, Arnaud Cancers (Basel) Article SIMPLE SUMMARY: The quantification of PD-L1 expression in tumor samples through the tumor proportion score (TPS) and the combined positive score (CPS) conditions provides access to anti-PD-1/PD-L1 immunotherapy in patients with various solids cancers. Reproducibility studies have shown very heterogeneous inter- and intra-pathologist agreements, from poor to excellent ones, in TPS and CPS quantification. We studied the inter- and intra-pathologist agreements in TPS and CPS quantification comparing single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor nuclear markers, trying to improve the distinction between tumor cells and immune cells necessary to TPS and CPS calculations. Our study concluded in excellent (TPS) to good (CPS) inter- and intra-pathologist agreements with both S-IHC and D-IHC with slightly higher intraclass correlation coefficients using D-IHC. D-IHC could help the pathologists to quantify PD-L1 expression through TPS and CPS for subsequent therapeutic choices in patients with advanced cancers. ABSTRACT: We studied the pathologists’ agreements in quantifying PD-L1 expression through the tumor proportion score (TPS) and the combined positive score (CPS) using single PD-L1 immunohistochemistry (S-IHC) and double immunohistochemistry (D-IHC) combining PD-L1 staining and tumor cell markers. S-IHC and D-IHC were applied to 15 cancer samples to generate 60 digital IHC slides (30 whole slides images and 30 regions of interest of 1 mm(2)) for PD-L1 expression quantification using both TPS and CPS, twice by four pathologists. Agreements were estimated calculating intraclass correlation coefficients (ICC). Both S-IHC and D-IHC slides analyses resulted in excellent (for TPS, ICC > 0.9) to good (for CPS, ICC > 0.75) inter- and intra-pathologist agreements with slightly higher ICC with D-IHC than with S-IHC. S-IHC resulted in higher TPS and CPS than D-IHC (+5.6 and +6.1 mean differences, respectively). High reproducibility in the quantification of PD-L1 expression is attainable using S-IHC and D-IHC. MDPI 2023-05-16 /pmc/articles/PMC10216272/ /pubmed/37345105 http://dx.doi.org/10.3390/cancers15102768 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Mercier, Anaïs Conan-Charlet, Virginie Quintin-Roué, Isabelle Doucet, Laurent Marcorelles, Pascale Uguen, Arnaud Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title | Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title_full | Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title_fullStr | Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title_full_unstemmed | Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title_short | Reproducibility in PD-L1 Immunohistochemistry Quantification through the Tumor Proportion Score and the Combined Positive Score: Could Dual Immunostaining Help Pathologists? |
title_sort | reproducibility in pd-l1 immunohistochemistry quantification through the tumor proportion score and the combined positive score: could dual immunostaining help pathologists? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216272/ https://www.ncbi.nlm.nih.gov/pubmed/37345105 http://dx.doi.org/10.3390/cancers15102768 |
work_keys_str_mv | AT mercieranais reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists AT conancharletvirginie reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists AT quintinroueisabelle reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists AT doucetlaurent reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists AT marcorellespascale reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists AT uguenarnaud reproducibilityinpdl1immunohistochemistryquantificationthroughthetumorproportionscoreandthecombinedpositivescorecoulddualimmunostaininghelppathologists |